Ozturk B - Search Results

1

Modified outpatient dexamethazone, cytarabine and cisplatin regimen may lead to high response rates and low toxicity in lymphoma.

Kanat O, Ozet A, Ataergin S, Arpaci F, Kuzhan O, Komurcu S, Ozturk B, Ozturk M. Kanat O, et al. Among authors: ozturk m, ozturk b. Med Princ Pract. 2010;19(5):344-7. doi: 10.1159/000316370. Epub 2010 Jul 14. Med Princ Pract. 2010. PMID: 20639655 Free article. Clinical Trial.

2

Self-reported experience of mucositis in cancer patients who underwent conditioning regimen and stem cell transplantation.

Ozturk M, Komurcu S, Kilic S, Ozet A, Arpaci F, Ozturk B, Kuzhan O, Ataergin S. Ozturk M, et al. Among authors: ozturk b. Support Care Cancer. 2009 Oct;17(10):1295-9. doi: 10.1007/s00520-009-0586-6. Epub 2009 Feb 6. Support Care Cancer. 2009. PMID: 19198890

3

Isolated renal relapse of a case with non-Hodgkin's lymphoma.

Turk HM, Ozet A, Ozturk M, Komurcu S, Kuzhan O, Arpaci F, Ozturk B, Safali M. Turk HM, et al. Among authors: ozturk m, ozturk b. Med Oncol. 2010 Jun;27(2):434-8. doi: 10.1007/s12032-009-9229-5. Epub 2009 May 13. Med Oncol. 2010. PMID: 19437146

4

Cumulative prior dose of cisplatin as a cause of the nephrotoxicity of high-dose chemotherapy followed by autologous stem-cell transplantation.

Caglar K, Kinalp C, Arpaci F, Turan M, Saglam K, Ozturk B, Komurcu S, Yavuz I, Yenicesu M, Ozet A, Vural A. Caglar K, et al. Among authors: ozturk b. Nephrol Dial Transplant. 2002 Nov;17(11):1931-5. doi: 10.1093/ndt/17.11.1931. Nephrol Dial Transplant. 2002. PMID: 12401849

5

A 10-year delayed breast cancer patient with unusual widespread cutaneous involvement and visceral metastases.

Ozet A, Yilmaz MI, Yavuz AA, Ozturk B, Komurcu S, Arpaci F. Ozet A, et al. Among authors: ozturk b. Breast J. 2003 Jan-Feb;9(1):54-5. doi: 10.1046/j.1524-4741.2003.09110.x. Breast J. 2003. PMID: 12558675 No abstract available.

6

The feasibility of neoadjuvant high-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with nonmetastatic high grade localized osteosarcoma: results of a phase II study.

Arpaci F, Ataergin S, Ozet A, Erler K, Basbozkurt M, Ozcan A, Komurcu S, Ozturk B, Celasun B, Kilic S, Kuzhan O. Arpaci F, et al. Among authors: ozturk b. Cancer. 2005 Sep 1;104(5):1058-65. doi: 10.1002/cncr.21279. Cancer. 2005. PMID: 15999369 Free article. Clinical Trial.

7

Treatment of primary cutaneous B-cell lymphoma with radiotherapy.

Ulutin HC, Oztürk B, Ongürü O, Kuzhan O, Arpaci F, Ozet A. Ulutin HC, et al. Among authors: ozturk b. Radiat Med. 2005 Jun;23(4):292-5. Radiat Med. 2005. PMID: 16012406

8

Survival benefit with GM-CSF use after high-dose chemotherapy in high-risk breast cancer.

Kuzhan O, Ozet A, Ulutin C, Kömürcü S, Arpaci F, Oztürk B, Oztürk M. Kuzhan O, et al. Among authors: ozturk m, ozturk b. Tumori. 2007 Nov-Dec;93(6):550-6. doi: 10.1177/030089160709300606. Tumori. 2007. PMID: 18338488

9

Paraneoplastic motor neuron disease resembling amyotrophic lateral sclerosis in a patient with renal cell carcinoma.

Turk HM, Ozet A, Kuzhan O, Komurcu F, Arpaci F, Ozturk B, Ataergin S. Turk HM, et al. Among authors: ozturk b. Med Princ Pract. 2009;18(1):73-5. doi: 10.1159/000163053. Epub 2008 Dec 4. Med Princ Pract. 2009. PMID: 19060497 Free article.

10

The clinical significance of tumor cells in bone marrow or apheresis product and the efficacy of CD34+ selection and high-dose chemotherapy in patients with Stage III breast cancer.

Arpaci F, Safali M, Ozet A, Ural AU, Cetin T, Ozturk M, Ataergin S, Kuzhan O, Komurcu S, Ozturk B, Acikel C. Arpaci F, et al. Among authors: ozturk m, ozturk b. J Clin Apher. 2009;24(5):197-204. doi: 10.1002/jca.20211. J Clin Apher. 2009. PMID: 19816961 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

691 results

Search Page